04-20289. Scientific Considerations Related to Developing Follow-On Protein Products; Correction  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice of public workshop; correction.

    SUMMARY:

    The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of August 16, 2004 (69 FR 50386). The document announced a public workshop on scientific and technical considerations related to the development of follow-on protein pharmaceutical products. The document was published with an inadvertent error. This document corrects that error.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Joyce Strong, Office of Policy (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.

    End Further Info

    In FR Doc. 04-18627 appearing on page 50386 in the issue of August 16, 2004, the following correction is made: On page 50386, in the third column, under the heading ADDRESSES, in the second paragraph add a new second sentence to read: Submit electronic comments to http://www.fda.gov/​dockets/​ecomments.

    Start Signature

    Dated: August 31, 2004.

    William K. Hubbard,

    Associate Commissioner for Policy and Planning.

    End Signature End Preamble

    [FR Doc. 04-20289 Filed 9-1-04; 4:34 pm]

    BILLING CODE 4160-01-S

Document Information

Published:
09/07/2004
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice of public workshop; correction.
Document Number:
04-20289
Pages:
54149-54149 (1 pages)
Docket Numbers:
Docket No. 2004N-0355
PDF File:
04-20289.pdf